Search Results - "Leong, Lucille"

p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy by Hardwick, Nicola R, Frankel, Paul, Ruel, Christopher, Kilpatrick, Julie, Tsai, Weimin, Kos, Ferdynand, Kaltcheva, Teodora, Leong, Lucille, Morgan, Robert, Chung, Vincent, Tinsley, Raechelle, Eng, Melissa, Wilczynski, Sharon, Ellenhorn, Joshua D I, Diamond, Don J, Cristea, Mihaela

“…To conduct a phase I trial of a Modified Vaccinia Ankara vaccine delivering wild-type human p53 (p53MVA) in combination with gemcitabine chemotherapy in…”
Get full text

Colon cancer, version 3.2014 by Benson, 3rd, Al B, Venook, Alan P, Bekaii-Saab, Tanios, Chan, Emily, Chen, Yi-Jen, Cooper, Harry S, Engstrom, Paul F, Enzinger, Peter C, Fenton, Moon J, Fuchs, Charles S, Grem, Jean L, Hunt, Steven, Kamel, Ahmed, Leong, Lucille A, Lin, Edward, Messersmith, Wells, Mulcahy, Mary F, Murphy, James D, Nurkin, Steven, Rohren, Eric, Ryan, David P, Saltz, Leonard, Sharma, Sunil, Shibata, David, Skibber, John M, Sofocleous, Constantinos T, Stoffel, Elena M, Stotsky-Himelfarb, Eden, Willett, Christopher G, Gregory, Kristina M, Freedman-Cass, Deborah A

“…The NCCN Guidelines for Colon Cancer address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance,…”
Get more information

A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study by LUU, Thehang H, MORGAN, Robert J, APARICIO, Ana, SOMLO, George, WONG, Carol, LEONG, Lucille, LIM, Dean, MCNAMARA, Mark, PORTNOW, Jana, FRANKEL, Paul, SMITH, David D, DOROSHOW, James H, GANDARA, David R

“…Purpose: The primary goal of this trial was to determine the response rate of single-agent vorinostat in patients with metastatic breast cancer. The secondary…”
Get full text

Achieving physician well-being: the best physicians are well physicians by Leong, Lucille A

Get more information

Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines by Benson, 3rd, Al B, Bekaii-Saab, Tanios, Chan, Emily, Chen, Yi-Jen, Choti, Michael A, Cooper, Harry S, Engstrom, Paul F, Enzinger, Peter C, Fakih, Marwan G, Fenton, Moon J, Fuchs, Charles S, Grem, Jean L, Hunt, Steven, Kamel, Ahmed, Leong, Lucille A, Lin, Edward, May, Kilian Salerno, Mulcahy, Mary F, Murphy, Kate, Rohren, Eric, Ryan, David P, Saltz, Leonard, Sharma, Sunil, Shibata, David, Skibber, John M, Small, Jr, William, Sofocleous, Constantinos T, Venook, Alan P, Willett, Christopher G, Gregory, Kristina M, Freedman-Cass, Deborah A

“…The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care…”
Get more information

Rectal cancer by Benson, 3rd, Al B, Bekaii-Saab, Tanios, Chan, Emily, Chen, Yi-Jen, Choti, Michael A, Cooper, Harry S, Engstrom, Paul F, Enzinger, Peter C, Fakih, Marwan G, Fuchs, Charles S, Grem, Jean L, Hunt, Steven, Leong, Lucille A, Lin, Edward, Martin, Michael G, May, Kilian Salerno, Mulcahy, Mary F, Murphy, Kate, Rohren, Eric, Ryan, David P, Saltz, Leonard, Sharma, Sunil, Shibata, David, Skibber, John M, Small, Jr, William, Sofocleous, Constantinos T, Venook, Alan P, Willett, Christopher G, Freedman-Cass, Deborah A, Gregory, Kristina M

“…These NCCN Clinical Practice Guidelines in Oncology provide recommendations for the management of rectal cancer, beginning with the clinical presentation of…”
Get more information

Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines by Benson, 3rd, Al B, Bekaii-Saab, Tanios, Chan, Emily, Chen, Yi-Jen, Choti, Michael A, Cooper, Harry S, Engstrom, Paul F, Enzinger, Peter C, Fakih, Marwan G, Fenton, Moon J, Fuchs, Charles S, Grem, Jean L, Hunt, Steven, Kamel, Ahmed, Leong, Lucille A, Lin, Edward, May, Kilian Salerno, Mulcahy, Mary F, Murphy, Kate, Rohren, Eric, Ryan, David P, Saltz, Leonard, Sharma, Sunil, Shibata, David, Skibber, John M, Small, Jr, William, Sofocleous, Constantinos T, Venook, Alan P, Willett, Christopher G, Gregory, Kristina M, Freedman-Cass, Deborah A

“…The NCCN Clinical Practice Guidelines in Oncology for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or…”
Get more information

Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines by Benson, 3rd, Al B, Arnoletti, J Pablo, Bekaii-Saab, Tanios, Chan, Emily, Chen, Yi-Jen, Choti, Michael A, Cooper, Harry S, Dilawari, Raza A, Engstrom, Paul F, Enzinger, Peter C, Fakih, Marwan G, Fleshman, Jr, James W, Fuchs, Charles S, Grem, Jean L, Leong, Lucille A, Lin, Edward, May, Kilian Salerno, Mulcahy, Mary F, Murphy, Kate, Rohren, Eric, Ryan, David P, Saltz, Leonard, Sharma, Sunil, Shibata, David, Skibber, John M, Small, Jr, William, Sofocleous, Constantinos T, Venook, Alan P, Willett, Christopher, Freedman-Cass, Deborah A

“…The workup and management of squamous cell anal carcinoma, which represents the most common histologic form of the disease, are addressed in the NCCN Clinical…”
Get more information

Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer by Gupta, Rohan, Cristea, Mihaela, Frankel, Paul, Ruel, Christopher, Chen, Chen, Wang, Yingyu, Morgan, Robert, Leong, Lucille, Chow, Warren, Koczywas, Marianna, Koehler, Steve, Lim, Dean, Luu, Thehang, Martel, Cynthia, McNamara, Mark, Somlo, George, Twardowski, Przemyslaw, Yen, Yun, Idorenyi, Amanam, Raechelle, Tinsley, Carroll, Mary, Chung, Vincent

“…Oral metronomic chemotherapy, which has low toxicity, has demonstrated promising anti-tumor and anti-angiogenic properties that may lead to prolonged…”
Get full text

A Phase I Study of a Combination of Yttrium-90–Labeled Anti–Carcinoembryonic Antigen (CEA) Antibody and Gemcitabine in Patients with CEA-Producing Advanced Malignancies by SHIBATA, Stephen, RAUBITSCHEK, Andrew, LEONG, Lucille, KOCZYWAS, Marianna, WILLIAMS, Lawrence, JIPING ZHAN, WONG, Jeffrey Y. C

“…Purpose: To determine the maximum tolerated dose of combined therapy using an yttrium-90–labeled anti–carcinoembryonic antigen (CEA) antibody with gemcitabine…”
Get full text

Colon cancer by Benson, 3rd, Al B, Arnoletti, J Pablo, Bekaii-Saab, Tanios, Chan, Emily, Chen, Yi-Jen, Choti, Michael A, Cooper, Harry S, Dilawari, Raza A, Engstrom, Paul F, Enzinger, Peter C, Fleshman, Jr, James W, Fuchs, Charles S, Grem, Jean L, Knol, James A, Leong, Lucille A, Lin, Edward, May, Kilian Salerno, Mulcahy, Mary F, Murphy, Kate, Rohren, Eric, Ryan, David P, Saltz, Leonard, Sharma, Sunil, Shibata, David, Skibber, John M, Small, Jr, William, Sofocleous, Constantinos T, Venook, Alan P, Willett, Christopher

Get more information

Rectal Cancer, Version 2.2015 by Benson, 3rd, Al B, Venook, Alan P, Bekaii-Saab, Tanios, Chan, Emily, Chen, Yi-Jen, Cooper, Harry S, Engstrom, Paul F, Enzinger, Peter C, Fenton, Moon J, Fuchs, Charles S, Grem, Jean L, Grothey, Axel, Hochster, Howard S, Hunt, Steven, Kamel, Ahmed, Kirilcuk, Natalie, Leong, Lucille A, Lin, Edward, Messersmith, Wells A, Mulcahy, Mary F, Murphy, James D, Nurkin, Steven, Rohren, Eric, Ryan, David P, Saltz, Leonard, Sharma, Sunil, Shibata, David, Skibber, John M, Sofocleous, Constantinos T, Stoffel, Elena M, Stotsky-Himelfarb, Eden, Willett, Christopher G, Gregory, Kristina M, Freedman-Cass, Deborah

“…The NCCN Guidelines for Rectal Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address…”
Get more information

Tandem High-dose Chemotherapy Followed by Autologous Transplantation in Patients with Locally Advanced or Metastatic Sarcoma by LASHKARI, Ashkan, CHOW, Warren A, SOMLO, George, VALDES, Frances, LEONG, Lucille, PHAN, V. U, TWARDOWSKI, Przemyslaw, KAPOOR, Neena, MOLINA, Arturo, AL-KADHIMI, Zaid, FRANKEL, Paul

“…Background: Patients with locally advanced or metastatic/recurrent soft tissue and Ewing's sarcoma (EWS) have few treatment options. The purpose of our phase…”
Get full text

Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity by Morgan, Jr, Robert J, Synold, Timothy W, Xi, Bixin, Lim, Dean, Shibata, Stephen, Margolin, Kim, Schwarz, Roderich E, Leong, Lucille, Somlo, George, Twardowski, Przemyslaw, Yen, Yun, Chow, Warren, Tetef, Merry, Lin, Paul, Paz, Benjamin, Koczywas, Mariana, Wagman, Lawrence, Chu, David, Frankel, Paul, Stalter, Susan, Doroshow, James H

“…Purpose: To determine the maximally tolerated dose, toxicity, and pharmacokinetics of i.p. gemcitabine. Experimental Design: Patients had peritoneal…”
Get full text

Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial by Yen, Y, Lim, Dean W, Chung, Vincent, Morgan, Robert J, Leong, Lucille A, Shibata, Stephen I, Wagman, Lawrence D, Wagman, Stephen D, Marx, Howard, Chu, Peiguo G, Longmate, Jeffrey A, Lenz, Heinz-Josef, Ramanathan, Ramesh K, Belani, Chandra P, Gandara, David R

“…Prolonged survival for patients with unresectable hepatocellular carcinoma (HCC) is consistently reported at lower than 6 months. Oxaliplatin has recently…”
Get full text

Prognostic Indicators and Survival in Patients With Stage IIIB Inflammatory Breast Carcinoma After Dose-Intense Chemotherapy by SOMLO, George, FRANKEL, Paul, TWARDOWSKI, Przemyslaw, WEITZEL, Jeffrey, ALVARNAS, Joseph, KOGUT, Neil, SCHRIBER, Jeffrey, FERMIN, Eleanor, YUN YEN, DAMON, Lloyd, DOROSHOW, James H, CHOW, Warren, LEONG, Lucille, MARGOLIN, Kim, MORGAN, Robert JR, SHIBATA, Stephen, PEIGUO CHU, FORMAN, Stephen, LIM, Dean

“…To improve treatment outcome for patients presenting with inflammatory breast cancer (IBC), we have sequentially developed and tested single and tandem…”
Get full text

Chemotherapy for metastatic colorectal cancer by Rosales, Joseph, Leong, Lucille A

“…The past decade has seen a significant survival improvement for patients with metastatic colorectal cancer, fueled in large part by the arrival of active novel…”
Get more information

Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study by Shibata, Stephen I, Doroshow, James H, Frankel, Paul, Synold, Timothy W, Yen, Yun, Gandara, David R, Lenz, Heinz-Josef, Chow, Warren A, Leong, Lucille A, Lim, Dean, Margolin, Kim A, Morgan, Robert J, Somlo, George, Newman, Edward M

“…Background GTI-2040 is a 20-mer antisense oligonucleotide targeting the mRNA of ribonucleotide reductase M2. It was combined with oxaliplatin and capecitabine…”
Get full text

Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy by Lim, Dean, Morgan, Jr, Robert J, Akman, Steven, Margolin, Kim, Carr, Brian I, Leong, Lucille, Odujinrin, Oluwole, Doroshow, James H

“…Based on the activity of menadione (M) in the human tumor stem cell assay, we conducted a phase I trial of M in patients with advanced cancer. Forty patients…”
Get full text

Improved Hepatic Toxicity Profile of Portal Vein Adjuvant Hepatic Infusional Chemotherapy by FAYNSOD, Moshe, WAGMAN, Lawrence D, LONGMATE, Jeff, CARROLL, Mary, LEONG, Lucille A

“…To determine whether floxuridine (FUDR) can be delivered with low hepatic toxicity through the portal vein (PV) as an adjuvant to surgically treated colorectal…”
Get full text